International Heart Journal 2011-01-01

Combined effect of disopyramide and erythromycin on ventricular repolarization in dogs with complete atrioventricular block.

Ichiro Watanabe, Yasuo Okumura, Koichi Nagashima, Masayoshi Kofune, Kimie Ohkubo, Hiroaki Mano, Kazumasa Sonoda, Yuji Kasamaki, Atsushi Hirayama

Index: Int. Heart J. 52(6) , 393-7, (2011)

Full Text: HTML

Abstract

The combined effects of disopyramide (DP) and erythromycin (EM) on ventricular repolarization and the inciden-ces of ventricular premature contractions (VPCs) and torsades de pointes (TdP) were investigated in 12 anesthetized dogs with complete atrioventricular block. Monophasic action potentials (MAPs) were measured from the left and right ventricular (LV and RV) endocardium. The right or left ventricle was paced at a cycle length of 750-1000 msec. Dogs were divided into 2 groups and given either intravenous DP at 3 mg/kg and then intravenous EM at 50 mg/kg (group 1, n = 8), or intravenous EM at 50 mg/kg and then intravenous DP at 3 mg/kg (group 2, n = 4). MAP duration at 90% repolarization (MAPD(90)) was measured before drug administration (baseline) and again after administration of each drug. RV MAPD(90) and LV MAPD(90) increased significantly (P < 0.02) after administration of each drug in group 1 (RV MAPD(90): from 247.0 ± 36.3 [baseline] to 283.5 ± 38.3 to 321.8 ± 56.7; LV MAPD(90): from 262.6 ± 49.1 (baseline) to 296.1 ± 58.8 to 351.0 ± 80.6). Early afterdepolarizations developed in 2 group 1 dogs after administration of DP and in 4 additional dogs after administration of EM. Frequent VPCs occurred in 1 dog after administration of DP and in 2 additional dogs after administration of EM, and TdP and ventricular tachycardias developed in 2 of the 3 dogs after administration of EM. Similar trends occurred in group 2. These results indicate a potentially fatal interaction between DP and EM administered in clinically relevant doses.


Related Compounds

  • Disopyramid phosph...

Related Articles:

A review of the effects of disopyramide phosphate on left ventricular function and the peripheral circulation.

1987-02-01

[Angiology 38(2 Pt 2) , 174-83, (1987)]

[Disopyramide phosphate: the electrophysiological mechanisms of its anti-arrhythmia action and its use in clinical practice].

1985-05-01

[Kardiologiia 25(5) , 114-8, (1985)]

Disopyramide-induced hypoglycemia in a non-diabetic hemodialysis patient: a case report and review of the literature.

2011-11-01

[Clin. Nephrol. 76(5) , 401-6, (2011)]

A primer of disopyramide treatment of obstructive hypertrophic cardiomyopathy.

2012-01-01

[Prog. Cardiovasc. Dis. 54(6) , 483-92, (2012)]

Monitoring disopyramide, lidocaine, and quinidine by micellar liquid chromatography.

2011-01-01

[J. AOAC Int. 94(2) , 537-42, (2011)]

More Articles...